Invention Grant
- Patent Title: Cell lines and their use in encapsulated cell biodelivery
-
Application No.: US14821498Application Date: 2015-08-07
-
Publication No.: US09884023B2Publication Date: 2018-02-06
- Inventor: Philip Kusk , Lars Ulrik Wahlberg
- Applicant: Gloriana Therapeutics sarl
- Applicant Address: CH Geneva
- Assignee: Gloriana Therapeutics sarl
- Current Assignee: Gloriana Therapeutics sarl
- Current Assignee Address: CH Geneva
- Agency: Feeney Law Group
- Agent Alan F. Feeney, Esq.
- Priority: DK200900103 20090123; DK200970121 20090922
- Main IPC: A61K9/48
- IPC: A61K9/48 ; C12N15/90 ; A61K38/22 ; A61K38/18 ; C12N15/88 ; A61K48/00 ; A61K35/12
Abstract:
The present invention relates to generation of cell lines expressing recombinant proteins for use in naked and encapsulated cell biodelivery of secreted therapeutic molecules. In one embodiment the cell line is human. In another aspect of the invention the transposon system is used for generating a cell line for secretion of a biologically active polypeptide.
Public/Granted literature
- US20150335587A1 CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY Public/Granted day:2015-11-26
Information query
